Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most common forms of chronic liver disease, particularly associated with obesity and type 2 diabetes mellitus. The prevalence has been increasing in recent years, currently affecting around 25% of the world's population. The hallmark of its pathophysiology lies in insulin resistance and the accumulation of fat inside hepatocytes. Sev...